Similar articles

• Topical microbicides for disease prevention: status and challenges.

  Harrison PF, Rosenberg Z, Bowcut J. Harrison PF, et al. Clin Infect Dis. 2003 May 15;36(10):1290-4. doi: 10.1086/374834. Epub 2003 May 8. Clin Infect Dis. 2003. PMID: 12746775
• A cause for optimism: microbicides pipeline shows promise.

  McCord A. McCord A. Proj Inf Perspect. 2008 Sep;(46):24-5. Proj Inf Perspect. 2008. PMID: 19048680 No abstract available.
• Microbicides and other topical agents in the prevention of HIV and sexually transmitted infections.

  Nikolic DS, Garcia E, Piguet V. Nikolic DS, et al. Expert Rev Anti Infect Ther. 2007 Feb;5(1):77-88. doi: 10.1586/14787210.5.1.77. Expert Rev Anti Infect Ther. 2007. PMID: 17266456 Review.
• Microbicides now.

  Forrest S. Forrest S. Posit Living. 2001 Apr;10(3):31-3, 38. Posit Living. 2001. PMID: 11548374 No abstract available.
• [The acceptability on vaginal microbicides to prevent human immunodeficiency virus/sexually transmitted diseases].

  Han L, Wu ZL. Han L, et al. Zhonghua Liu Xing Bing Xue Za Zhi. 2009 Feb;30(2):196-8. Zhonghua Liu Xing Bing Xue Za Zhi. 2009. PMID: 19565887 Review. Chinese. No abstract available.